Accepted at 1:41 p.m. Jul, 09, 2024 by IantheBFG
Author: mohannadkh10
Related Note: 1488850179982
Rationale for change

Uworld "early treatment with fibrinolytics, namely recombinant forms of tissue plasminogen activator (eg, tenecteplase, alteplase), improves clinical outcomes"
Source: UWorld - Step 1 823

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::04_Thrombolytics #AK_Step1_v12::#AMBOSS::GQaBx4 #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::07_Coagulation_and_Fibrinolysis::04_Fibrinolysis_and_Inhibitors_of_Hemostasis #AK_Step1_v12::#Pixorize::03_Pharmacology::11_Heme_Pharm::05_Thrombolytics_(tPA/Streptokinase/Urokinase) #AK_Step1_v12::#Physeo::09_Pharm::17_Hem/Onc_Pharm::04_Thrombolytics #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Cardiology::ACS_management #AK_Step1_v12::#Bootcamp::Cardiology::24_Myocardial_Infarction::06_Management #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::07_Thrombolytics #AK_Step2_v12::#B&B::02_Cardio::02_Ischemic_Heart_Disease::02_STEMI #AK_Step1_v12::#UWorld::COMLEX::23935 #AK_Step2_v12::#Bootcamp::Medicine::01_Cardiology::01_Coronary_Artery_Disease::05_Assessment_and_Management_of_ACS #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb::ACS_management #AK_Step1_v12::#UWorld::Step::823